Targets to retard the progression of diabetic nephropathy

被引：25

作者：

Cooper, ME ^{[1
]}

Jandeleit-Dahm, K ^{[1
]}

Thomas, MC ^{[1
]}

机构：

[1] Baker Med Res Inst, Danielle Alberti Mem Ctr Diabet Complicat, Melbourne, Vic 8008, Australia

来源：

KIDNEY INTERNATIONAL | 2005年 / 68卷 / 04期

关键词：

D O I：

10.1111/j.1523-1755.2005.00555.x

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1439 / 1445

页数：7

共 50 条

[1] Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy [J].

Barnett, AH ;

Bain, SC ;

Bouter, P ;

Karlberg, B ;

Madsbad, S ;

Jervell, J ;

Mustonen, J .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (19) :1952-1961

[2] DECLINING INCIDENCE OF NEPHROPATHY IN INSULIN-DEPENDENT DIABETES-MELLITUS [J].

BOJESTIG, M ;

ARNQVIST, HJ ;

HERMANSSON, G ;

KARLBERG, BE ;

LUDVIGSSON, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (01) :15-18

[3] Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy [J].

Bolton, WK ;

Cattran, DC ;

Williams, ME ;

Adler, SG ;

Appel, GB ;

Cartwright, K ;

Foiles, PG ;

Freedman, BI ;

Raskin, P ;

Ratner, RE ;

Spinowitz, BS ;

Whittier, FC ;

Wuerth, JP .

AMERICAN JOURNAL OF NEPHROLOGY, 2004, 24 (01) :32-40

[4]

Bonnet F, 2000, DIABETES METAB, V26, P254

[5] Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy [J].

Brenner, BM ;

Cooper, ME ;

de Zeeuw, D ;

Keane, WF ;

Mitch, WE ;

Parving, HH ;

Remuzzi, G ;

Snapinn, SM ;

Zhang, ZX ;

Shahinfar, S .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :861-869

[6] Effects of erythropoietin and aminoguanidine on red blood cell deformability in diabetic azotemic and uremic patients [J].

Brown, CD ;

Zhao, ZH ;

Thomas, LL ;

deGroof, R ;

Friedman, EA .

AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 38 (06) :1414-1420

[7] Biochemistry and molecular cell biology of diabetic complications [J].

Brownlee, M .

NATURE, 2001, 414 (6865) :813-820

[8] Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? A meta-analysis of individual patient data [J].

Chaturvedi, N .

ANNALS OF INTERNAL MEDICINE, 2001, 134 (05) :370-379

[9] Risk factors for renal failure: The WHO multinational study of vascular disease in diabetes [J].

Colhoun, HM ;

Lee, ET ;

Bennett, PH ;

Lu, M ;

Keen, H ;

Wang, SL ;

Stevens, LK ;

Fuller, JH .

DIABETOLOGIA, 2001, 44 (Suppl 2) :S46-S53

[10]

Collins R, 2003, LANCET, V361, P2005

← 1 2 3 4 5 →